Work

Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE Trial.

FWCI: 2.253
Cites:
Cited by: 32
Related to: 10